JAZZ Stock AnalysisJazz Pharmaceuticals plc · current price $244.60 (-2.53% today)
Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.
Reading JAZZ’s price and volume history…
Checking the areas that decide this thesis…
AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.
Reading JAZZ’s filings…
| Quarter | EPS | Est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | $8.13 | $5.85 | +39.0% | Beat |
| 2025-12-31 | $6.64 | $6.51 | +2.0% | Beat |
| 2026-03-31 | $6.34 | $4.66 | +36.2% | Beat |
| 2026-06-30 | $5.71 | $6.18 | -7.5% | Miss |
Jazz Pharmaceuticals plc (JAZZ) currently has a TickerMover Quant Score of 64/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.
TickerMover does not give buy or sell recommendations. JAZZ scores 64/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.
JAZZ's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.
Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.
Open the dashboard for JAZZ →
